Troponin I, slow skeletal muscle (TNNI1)

Troponin I, slow skeletal muscle (TNNI1), also known as ssTnI, is a critical regulatory protein found in slow-twitch (Type I) skeletal muscle fibers and embryonic cardiac tissue. As the inhibitory subunit of the heterotrimeric troponin complex, it prevents muscle contraction in the absence of calcium by blocking the myosin-binding sites on actin filaments. During postnatal development, the heart undergoes an isoform switch where ssTnI is replaced by cardiac troponin I (cTnI); disruptions in this process or mutations in the TNNI1 gene are linked to various muscle disorders, including nemaline myopathy and other congenital myopathies characterized by either hypo- or hypercontractility. TNNI1 is an emerging therapeutic target for slow skeletal muscle troponin activators (SSTAs) aimed at improving muscle function in neuromuscular diseases, while its serum levels serve as a highly specific biomarker for slow-fiber-specific skeletal muscle injury. Recent research also highlights its potential role in cardiac regeneration and its utility in monitoring muscle toxicity from drugs like statins.

Other names

ssTnITroponin I1Troponin I type 1SSTNITNN1Troponin I, slow-twitch isoform

Troponin I acts as the inhibitory subunit of the troponin complex, blocking the interaction between actin and myosin in the absence of calcium. Troponin activators (calcium sensitizers) bind to the troponin complex to increase its sensitivity to calcium, thereby stabilizing the 'on' state of the thin filament and enhancing muscle contraction force at submaximal calcium concentrations.